Comment on Better Buy: CRISPR Therapeutics AG vs. Intellia Therapeutics Inc.

Better Buy: CRISPR Therapeutics AG vs. Intellia Therapeutics Inc.

Looking for a way to invest in the "biggest biotech discovery of the century" -- CRISPR gene editing? Two of the top candidates are CRISPR Therapeutics AG (NASDAQ: CRSP) and Intellia Therapeutics, Inc. (NASDAQ: NTLA). Both biotechs are focused on harnessing CRISPR gene editing to fight disease.CRISPR Therapeutics is the hands-down winner in terms of stock performance so far in 2018.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News